CDC extends review of Johnson & Johnson vaccine amid pause over rare blood clot cases
An emergency meeting of a Centers for Disease Control and Prevention advisory committee was held to discuss the extremely rare blood clots possibly associated with the Johnson and Johnson COVID-19 vaccine. The meeting ended without a decision on when the shots can be given again. CBS News' Laura Podesta joined "CBSN AM" with the latest.